Tech Nation introduce 33 UK scaleups that have been selected to join Upscale 6.0. Upscale is one of Tech Nation’s flagship growth programmes, focused on helping the fastest growing mid-stage tech companies in the UK to tackle their key scaling challenges. Liam Ward, Upscale Programme Lead, Tech Nation said:
“We’re incredibly excited to launch Upscale 6.0, our most regionally diverse cohort ever, alongside the Scale Ratio Report, and to continue to champion and support the UK’s most exciting fast-growth companies.
Despite the events of the last 12 months, we’re seeing some exceptional companies scaling at Series A stage, with healthtech and the future of work being represented particularly strongly. We’re excited to adapt Upscale to support the new challenges that founders are facing around remote work, fundraising and culture; and to work with such an exciting group of leaders.”
The Upscale programme has a prestigious reputation, having featured companies like Monzo, Bulb and Depop in the past, and with last year’s cohort including such scaling stars as Thriva, Chattermill, Kheiron Medical and Farewill. With that in mind, the 33 companies chosen by the panel of tech and scaling experts, which included Cherry Freeman, co-founder of Lovecrafts, Dominic Jacquesson, VP of Talent at Index, and Bloom & Wild co-founder Aron Gelbard, are certain to be the scaling stars of 2021.
“I was thrilled to take part in the judging process for Upscale this year and see how competitive the applications were. Our leadership team really benefited from our time on Upscale in 2016, and now as an alumni of the programme, it’s great to be able to share my experience scaling Bloom & Wild as both a judge and speaker with a new group of founders scaling the UK’s most exciting companies.” Aron Gelbard, co-founder, Bloom & Wild
The Upscale 6.0 cohort, which features the UK’s best performing tech companies, is skewed towards healthtech companies, representing 18% of the total cohort. It reflects how healthtech companies have come to the fore of UK tech, especially in the wake of the pandemic.
The UK is now third in the world for healthtech investment after the US and China, and over the course of 2020 we saw an increase in early stage investment, from $2.27bn in 2019 to $2.32bn in 2020.
Healthtech companies joining the Upscale programme include: London-based LabGenius, which develops new protein-based drugs using machine learning – lowering the associated costs and risks of drug development; Belfast-based Locate a Locum, which enables temporary healthcare workers to connect; and Oxford-based Vitaccess, a platform which quantifies patients’ experiences of treatments and illness.
(Belfast, Healthtech & Biotech & Life Sciences)
Founder: Jonny Clarke
Mobilising the world’s healthcare workforce, Locate a Locum allows temporary healthcare workers and organisations to connect with each other in an easy and efficient way. Working to empower the workforce, they are giving every healthcare worker and healthcare organisation the power to manage their own work life.
The latest updates from Digital DNA
Early access to our events
+ lots more every 1-2 weeks